LKT Labs

Biochemicals for Life Science Research

Toremifene Base

Toremifene Base

Product ID T5769
Cas No. 89778-26-7
Purity ≥98%
Product Unit SizeCostQuantityStock
500 mg $109.00 In stock
1 g $174.00 In stock
5 g $649.00 In stock
Bulk Quote

Quicklinks

Description

Toremifene is a selective estrogen receptor modulator (SERM) that also moderates androgen receptor activity. Ite displays anticancer chemotherapeutic and anti-angiogenic activities. Clinically, this compound is used to treat breast cancer and prostate cancer. Toremifene decreases microvessel density and induces remission of benign fibrous lesions in clinical settings with subjects experiencing desmoid tumors. Additionally, it increases latency to tumor formation, decreases tumor number, and increases survival in animal models of prostate cancer.

Product Info

Cas No.

89778-26-7
Purity

≥98%
Formula

C26H28ClNO
Formula Wt.

405.96
Chemical Name

2-[4-[(1Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethanamine
IUPAC Name

2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N, N-dimethylethanamine
Synonym

Toremifene
Melting Point

108-110°C
Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

T5769 MSDS PDF
Info Sheet

T5769 Info Sheet PDF

References

Chang BY, Kim SA, Malla B, et al. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells. Toxicol Res. 2011 Jun;27(2):85-93. PMID: 24278556.

Kawashima H, Tanaka T, Cheng JS, et al. Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells. Urol Res. 2004 Dec;32(6):406-10. PMID: 15316697.

Heidemann J, Ogawa H, Otterson MF, et al. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum. 2004 Jan;47(1):118-22. PMID: 14719159.

Raghow S, Hooshdaran MZ, Katiyar S, et al. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res. 2002 Mar 1;62(5):1370-6. PMID: 11888907.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T6830

    Triadimefon

    Neurotoxin, mutagen.

    ≥98%
  • F0268

    Farnesol

    Sesquiterpene alcohol found in various essentia...

    ≥98%
  • A7034

    Aripiprazole

    D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...

    ≥98%
  • B1874

    Bestatin Hydrochloride

    Dipeptide; aminopeptidase (N/CD13) inhibitor.

    ≥98%
  • C2997

    Chymostatin

    Protease inhibitor.

    ≥95% (mixture of A, B, C)
  • S7870

    Streptozocin

    Nitrosourea-amino sugar conjugate, DNA cross-li...

    ≥98%
  • G1721

    Gefitinib

    EGFR inhibitor.

    ≥98%
  • C0377

    Catharanthine Sulfate

    Alkaloid found in Catharanthus, precursor in sy...

    ≥98%
  • M2400

    MG-132

    Proteasome inhibitor.

    ≥98%
  • M568268

    Mogroside IV

    Triterpenoid

    ≥98%
  • B1992

    Bexarotene

    RXR agonist.

    ≥98%
  • X1753

    Xenopsin

    Peptide hormone, neurotensin analog found in am...

    ≥95%
  • X4424

    XL-765

    PI3K and mTOR inhibitor.

    ≥98%
  • M1680

    5-Methoxyindole

    Core structure of melatonin; potential PPARγ a...

    ≥98%
  • W0247

    Walrycin B

    Walrycin response regulator inhibitor.

    ≥98%
  • B1655

    S-(N-Benzylthiocarbamoyl)-L-cysteine

    Cysteine conjugate of benzyl isothiocyanate (BI...

    ≥98%
  • A5061

    Ampalex

    Benzylpiperidine; AMPA potentiator.

    ≥98%
  • G6802

    Granisetron Hydrochloride

    5-HT3 antagonist.

    ≥98%
  • P9668

    Pyrantel Pamoate

    Mixture of pyrantel, a thiophene, and pamoic ac...

    ≥98%
  • A4577

    Alsterpaullone

    GSK-3 and CDK inhibitor.

    ≥98%